NCT01681368 2017-05-30Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal CancerNational Institutes of Health Clinical Center (CC)Phase 2 Terminated11 enrolled 19 charts
NCT01940172 2016-01-14Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian CancerTetraLogic PharmaceuticalsPhase 1 Completed27 enrolled